{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:32:00Z","timestamp":1786980720314,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["9456 and 12369"],"award-info":[{"award-number":["9456 and 12369"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10495-026-02310-5","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:51:04Z","timestamp":1778345464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autophagy-lysosomal dependency defines a vulnerable physiological state in drug-tolerant persister cells of triple-negative breast cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Essha","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Dharavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliva","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshiyar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Pratyusha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigneshwar Reddy","family":"Ashireddygari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Tammineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishna","family":"Adicherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandkumar","family":"Doijad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-1836","authenticated-orcid":false,"given":"Santosh Kumar","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"2310_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.21037\/atm.2020.03.194","volume":"8","author":"S Zhao","year":"2020","unstructured":"Zhao S, Zuo W-J, Shao Z-M, Jiang Y-Z (2020) Molecular subtypes and precision treatment of triple-negative breast cancer. Ann Transl Med 8:499\u2013499. https:\/\/doi.org\/10.21037\/atm.2020.03.194","journal-title":"Ann Transl Med"},{"key":"2310_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","volume":"497","author":"X Bai","year":"2021","unstructured":"Bai X, Ni J, Beretov J et al (2021) Triple-negative breast cancer therapeutic resistance: Where is the Achilles\u2019 heel? Cancer Lett 497:100\u2013111. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.016","journal-title":"Cancer Lett"},{"key":"2310_CR3","doi-asserted-by":"publisher","first-page":"32956","DOI":"10.1039\/d2ra02005j","volume":"12","author":"MA Subhan","year":"2022","unstructured":"Subhan MA (2022) Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics. RSC Adv 12:32956\u201332978. https:\/\/doi.org\/10.1039\/d2ra02005j","journal-title":"RSC Adv"},{"key":"2310_CR4","first-page":"2929","volume":"5","author":"X Dai","year":"2015","unstructured":"Dai X, Li T, Bai Z et al (2015) Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res 5:2929\u20132943","journal-title":"Am J Cancer Res"},{"key":"2310_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/BD-2010-0307.Triple","volume":"32","author":"JC Kathryn","year":"2012","unstructured":"Kathryn JC, Sireesha VG, Stanley L (2012) Triple Negative Breast Cancer Cell Lines: One Tool in the Search for Better Treatment of Triple Negative Breast Cancer. Breast Dis 32:35\u201348. https:\/\/doi.org\/10.3233\/BD-2010-0307.Triple","journal-title":"Breast Dis"},{"key":"2310_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L (2022) Treatment landscape of triple-negative breast cancer \u2014 expanded options, evolving needs. Nat Rev Clin Oncol 19:91\u2013113. https:\/\/doi.org\/10.1038\/s41571-021-00565-2","journal-title":"Nat Rev Clin Oncol"},{"key":"2310_CR7","unstructured":"World j surg\u2009\u2013\u20092016 - Agarwal - Outcomes of Triple-Negative Breast Cancers TNBC Compared with Non\u2010TNBC Does the.pdf"},{"key":"2310_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s40265-013-0091-6","volume":"73","author":"V Guarneri","year":"2013","unstructured":"Guarneri V, Dieci MV, Conte P (2013) Relapsed triple-negative breast cancer: Challenges and treatment strategies. Drugs 73:1257\u20131265. https:\/\/doi.org\/10.1007\/s40265-013-0091-6","journal-title":"Drugs"},{"key":"2310_CR9","doi-asserted-by":"publisher","unstructured":"Zhang Z, Qin S, Chen Y et al (2022) Inhibition of NPC 1 L 1 disrupts adaptive responses of drug-tolerant persister cells to chemotherapy. 1\u201320. https:\/\/doi.org\/10.15252\/emmm.202114903","DOI":"10.15252\/emmm.202114903"},{"key":"2310_CR10","doi-asserted-by":"publisher","unstructured":"Fu L, Chen Z (2022) Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure. 3\u20135. https:\/\/doi.org\/10.1038\/s41392-022-00940-0","DOI":"10.1038\/s41392-022-00940-0"},{"key":"2310_CR11","doi-asserted-by":"publisher","unstructured":"van Gils N, Verhagen HJMP, Broux M et al (2022) Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters. https:\/\/doi.org\/10.1016\/j.isci.2022.105013. iScience 25:","DOI":"10.1016\/j.isci.2022.105013"},{"key":"2310_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","volume":"184","author":"SK Rehman","year":"2021","unstructured":"Rehman SK, Haynes J, Collignon E et al (2021) Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy. Cell 184:226\u2013242e21. https:\/\/doi.org\/10.1016\/j.cell.2020.11.018","journal-title":"Cell"},{"key":"2310_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan SU, Fatima K, Aisha S, Malik F (2024) Unveiling the mechanisms and challenges of cancer drug resistance. Cell Commun Signal 22:109. https:\/\/doi.org\/10.1186\/s12964-023-01302-1","journal-title":"Cell Commun Signal"},{"key":"2310_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/1538-7445.am2017-1006","volume":"77","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ et al (2017) Abstract 1006: Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Cancer Res 77:1006\u20131006. https:\/\/doi.org\/10.1158\/1538-7445.am2017-1006","journal-title":"Cancer Res"},{"key":"2310_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13051118","volume":"13","author":"G De Conti","year":"2021","unstructured":"De Conti G, Dias MH, Bernards R (2021) Fighting drug resistance through the targeting of drug-tolerant persister cells. Cancers (Basel) 13:1\u201315. https:\/\/doi.org\/10.3390\/cancers13051118","journal-title":"Cancers (Basel)"},{"key":"2310_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101471","author":"M Chen","year":"2024","unstructured":"Chen M, Mainardi S, Lieftink C et al (2024) Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101471. 5:","journal-title":"Cell Rep Med"},{"key":"2310_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1541-7786.MCR-21-0038","volume":"20","author":"C Leonce","year":"2022","unstructured":"Leonce C, Saintigny P, Ortiz-Cuaran S (2022) Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer. Mol Cancer Res 20:11\u201329. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0038","journal-title":"Mol Cancer Res"},{"key":"2310_CR18","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","volume":"185","author":"H Kalkavan","year":"2022","unstructured":"Kalkavan H, Chen MJ, Crawford JC et al (2022) Article Sublethal cytochrome c release generates drug- tolerant persister cells ll ll Article Sublethal cytochrome c release generates drug-tolerant persister cells. Cell 185:3356\u20133374e22. https:\/\/doi.org\/10.1016\/j.cell.2022.07.025","journal-title":"Cell"},{"key":"2310_CR19","doi-asserted-by":"publisher","unstructured":"Aleksandrova KV (2024) mTOR pathway occupies a central role in the emergence of latent cancer cells. 1\u201311. https:\/\/doi.org\/10.1038\/s41419-024-06547-3","DOI":"10.1038\/s41419-024-06547-3"},{"key":"2310_CR20","doi-asserted-by":"publisher","unstructured":"You B, Xia T, Gu M et al (2022) CANCER RESEARCH | MOLECULAR CELL BIOLOGY AMPK \u2013 mTOR \u2013 Mediated Activation of Autophagy Promotes Formation of Dormant Polyploid Giant Cancer Cells. 846\u2013858. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-2342","DOI":"10.1158\/0008-5472.CAN-21-2342"},{"key":"2310_CR21","doi-asserted-by":"publisher","unstructured":"Khan SU, Pathania AS, Wani A, Fatima K (2022) Author Correction: Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor. Sci Rep 1\u20132. https:\/\/doi.org\/10.1038\/s41598-022-12521-w","DOI":"10.1038\/s41598-022-12521-w"},{"key":"2310_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.2022111241","volume":"42","author":"R Curnock","year":"2023","unstructured":"Curnock R, Yalci K, Palmfeldt J et al (2023) TFEB -dependent lysosome biogenesis is required for senescence. EMBO J 42:1\u201315. https:\/\/doi.org\/10.15252\/embj.2022111241","journal-title":"EMBO J"},{"key":"2310_CR23","doi-asserted-by":"publisher","unstructured":"Yim WWY, Mizushima N (2020) Lysosome biology in autophagy. Cell Discov 6. https:\/\/doi.org\/10.1038\/s41421-020-0141-7","DOI":"10.1038\/s41421-020-0141-7"},{"key":"2310_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tibs.2020.09.004","volume":"46","author":"P Saftig","year":"2021","unstructured":"Saftig P, Puertollano R (2021) How Lysosomes Sense, Integrate, and Cope with Stress. Trends Biochem Sci 46:97\u2013112. https:\/\/doi.org\/10.1016\/j.tibs.2020.09.004","journal-title":"Trends Biochem Sci"},{"key":"2310_CR25","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1158\/0008-5472.CAN-14-2312","volume":"75","author":"SK Guru","year":"2015","unstructured":"Guru SK, Pathania AS, Kumar S et al (2015) Secalonic Acid-D Represses HIF1\u03b1\/VEGF-Mediated Angiogenesis by Regulating the Akt\/mTOR\/p70S6K Signaling Cascade. Cancer Res 75:2886\u20132896. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2312","journal-title":"Cancer Res"},{"key":"2310_CR26","doi-asserted-by":"publisher","unstructured":"Feoktistova M, Geserick P, Leverkus M (2016) Crystal Violet Assay for Determining Viability of Cultured Cells. https:\/\/doi.org\/10.1101\/pdb.prot087379. Cold Spring Harb Protoc 2016:pdb.prot087379","DOI":"10.1101\/pdb.prot087379"},{"key":"2310_CR27","doi-asserted-by":"publisher","unstructured":"Chatterjee E, Sharma R, Dey B (2025) Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo. 1\u201319. https:\/\/doi.org\/10.3389\/fphar.2025.1544666","DOI":"10.3389\/fphar.2025.1544666"},{"key":"2310_CR28","doi-asserted-by":"publisher","unstructured":"Kumar S, Guru SK, Pathania AS et al (2013) Autophagy triggered by magnolol derivative negatively regulates angiogenesis. Cell Death Dis 4. https:\/\/doi.org\/10.1038\/cddis.2013.399","DOI":"10.1038\/cddis.2013.399"},{"key":"2310_CR29","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/nprot.2009.191","volume":"4","author":"F Debacq-Chainiaux","year":"2009","unstructured":"Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O (2009) Protocols to detect senescence-associated beta-galactosidase (SA-\u03b2gal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4:1798\u20131806. https:\/\/doi.org\/10.1038\/nprot.2009.191","journal-title":"Nat Protoc"},{"key":"2310_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/SCIADV.ADL1498","volume":"9","author":"N Wulansari","year":"2023","unstructured":"Wulansari N, Darsono WHW, Woo HJ et al (2023) Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson\u2019s disease-linked DNAJC6 mutations. Sci Adv 9:1\u201318. https:\/\/doi.org\/10.1126\/SCIADV.ADL1498","journal-title":"Sci Adv"},{"key":"2310_CR31","doi-asserted-by":"publisher","unstructured":"Singothu S, Kinkar D, Vulli D et al (2025) Dysregulation of Host Histone Acetylation by. https:\/\/doi.org\/10.1021\/acsinfecdis.5c00080","DOI":"10.1021\/acsinfecdis.5c00080"},{"key":"2310_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbt.23374","volume":"37","author":"A Panghal","year":"2023","unstructured":"Panghal A, Kumar V, Jena G (2023) Melphalan induced germ cell toxicity and dose-dependent effects of \u03b2-aminoisobutyric acid in experimental rat model: Role of oxidative stress, inflammation and apoptosis. J Biochem Mol Toxicol 37:1\u201318. https:\/\/doi.org\/10.1002\/jbt.23374","journal-title":"J Biochem Mol Toxicol"},{"key":"2310_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-34890-6","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Azizian NG, Sullivan DK, Li Y (2022) mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters. Nat Commun 13:1\u201313. https:\/\/doi.org\/10.1038\/s41467-022-34890-6","journal-title":"Nat Commun"},{"key":"2310_CR34","doi-asserted-by":"publisher","unstructured":"Fujimaki K, Li R, Chen H et al (2019) Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch. 116. https:\/\/doi.org\/10.1073\/pnas.1915905116","DOI":"10.1073\/pnas.1915905116"},{"key":"2310_CR35","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C et al (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556\u2013W560. https:\/\/doi.org\/10.1093\/nar\/gkz430","journal-title":"Nucleic Acids Res"},{"key":"2310_CR36","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy B (2021) Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J 19:4101\u20134109. https:\/\/doi.org\/10.1016\/j.csbj.2021.07.014","journal-title":"Comput Struct Biotechnol J"},{"key":"2310_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Akshaya S et al (2017) UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression. Neoplasia 19:649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002","journal-title":"Neoplasia"},{"key":"2310_CR38","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"JT Fekete","year":"2019","unstructured":"Fekete JT, Gy\u0151rffy B (2019) ROCplot.org: Validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer 145:3140\u20133151. https:\/\/doi.org\/10.1002\/ijc.32369","journal-title":"Int J Cancer"},{"key":"2310_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","volume":"42","author":"A Karimian","year":"2016","unstructured":"Karimian A, Ahmadi Y, Yousefi B (2016) Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst) 42:63\u201371. https:\/\/doi.org\/10.1016\/j.dnarep.2016.04.008","journal-title":"DNA Repair (Amst)"},{"key":"2310_CR40","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.15252\/embj.201695553","volume":"36","author":"R Yosef","year":"2017","unstructured":"Yosef R, Pilpel N, Papismadov N et al (2017) p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. EMBO J 36:2280\u20132295. https:\/\/doi.org\/10.15252\/embj.201695553","journal-title":"EMBO J"},{"key":"2310_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.44571","volume":"9","author":"HW Yang","year":"2020","unstructured":"Yang HW, Cappell SD, Jaimovich A et al (2020) Stress-mediated exit to quiescence restricted by increasing persistence in cdk4\/6 activation. Elife 9:1\u201316. https:\/\/doi.org\/10.7554\/eLife.44571","journal-title":"Elife"},{"key":"2310_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14102562","volume":"14","author":"C Bellio","year":"2022","unstructured":"Bellio C, Emperador M, Castellano P et al (2022) GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells. Cancers (Basel) 14:1\u201323. https:\/\/doi.org\/10.3390\/cancers14102562","journal-title":"Cancers (Basel)"},{"key":"2310_CR43","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-13-3456","volume":"74","author":"D Raha","year":"2014","unstructured":"Raha D, Wilson TR, Peng J et al (2014) The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer Res 74:3579\u20133590. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3456","journal-title":"Cancer Res"},{"key":"2310_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21217836","volume":"21","author":"S Cocco","year":"2020","unstructured":"Cocco S, Leone A, Piezzo M et al (2020) Targeting autophagy in breast cancer. Int J Mol Sci 21:1\u201322. https:\/\/doi.org\/10.3390\/ijms21217836","journal-title":"Int J Mol Sci"},{"key":"2310_CR45","doi-asserted-by":"publisher","unstructured":"Yu S, Cao Z, Cai F et al (2024) ADT-OH exhibits anti-metastatic activity on triple-negative breast cancer by combinatorial targeting of autophagy and mitochondrial fission. Cell Death Dis 15. https:\/\/doi.org\/10.1038\/s41419-024-06829-w","DOI":"10.1038\/s41419-024-06829-w"},{"key":"2310_CR46","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1080\/15548627.2020.1823124","volume":"17","author":"X Tian","year":"2021","unstructured":"Tian X, Teng J, Chen J (2021) New insights regarding SNARE proteins in autophagosome-lysosome fusion. Autophagy 17:2680\u20132688. https:\/\/doi.org\/10.1080\/15548627.2020.1823124","journal-title":"Autophagy"},{"key":"2310_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymeth.2014.11.021","volume":"75","author":"P Jiang","year":"2015","unstructured":"Jiang P, Mizushima N (2015) LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods 75:13\u201318. https:\/\/doi.org\/10.1016\/j.ymeth.2014.11.021","journal-title":"Methods"},{"key":"2310_CR48","doi-asserted-by":"publisher","unstructured":"Iovanna J, Vaccaro MI (2010) Quantitation of autophagy in the pancreas at the tissue and cell levels. 1\u201312. https:\/\/doi.org\/10.3998\/panc.2010.13","DOI":"10.3998\/panc.2010.13"},{"key":"2310_CR49","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","volume":"27","author":"EL Eskelinen","year":"2006","unstructured":"Eskelinen EL (2006) Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 27:495\u2013502. https:\/\/doi.org\/10.1016\/j.mam.2006.08.005","journal-title":"Mol Aspects Med"},{"key":"2310_CR50","doi-asserted-by":"publisher","unstructured":"Liu EA, Schultz ML, Mochida C et al (2020) Fbxo2 mediates clearance of damaged lysosomes and modifies neurodegeneration in the Niemann-Pick C brain. https:\/\/doi.org\/10.1172\/jci.insight.136676. JCI insight 5:","DOI":"10.1172\/jci.insight.136676"},{"key":"2310_CR51","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/s41467-018-04070-6","volume":"9","author":"L Vera-Ramirez","year":"2018","unstructured":"Vera-Ramirez L, Vodnala SK, Nini R et al (2018) Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence. Nat Commun 9:1944. https:\/\/doi.org\/10.1038\/s41467-018-04070-6","journal-title":"Nat Commun"},{"key":"2310_CR52","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1083\/jcb.201712058","volume":"217","author":"T Matsui","year":"2018","unstructured":"Matsui T, Jiang P, Nakano S et al (2018) Autophagosomal YKT6 is required for fusion with lysosomes independently of syntaxin 17. J Cell Biol 217:2633\u20132645. https:\/\/doi.org\/10.1083\/jcb.201712058","journal-title":"J Cell Biol"},{"key":"2310_CR53","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.3892\/ol.2017.6757","volume":"14","author":"Q Wang","year":"2017","unstructured":"Wang Q, Yao J, Jin Q et al (2017) LAMP1 expression is associated withpoor prognosis in breast cancer. Oncol Lett 14:4729\u20134735. https:\/\/doi.org\/10.3892\/ol.2017.6757","journal-title":"Oncol Lett"},{"key":"2310_CR54","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.4161\/auto.21654","volume":"8","author":"T Saha","year":"2012","unstructured":"Saha T (2012) LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy. Autophagy 8:1643\u20131656. https:\/\/doi.org\/10.4161\/auto.21654","journal-title":"Autophagy"},{"key":"2310_CR55","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/35022595","volume":"406","author":"Y Tanaka","year":"2000","unstructured":"Tanaka Y, Guhde G, Suter A et al (2000) Accumulation of autophagic vacuoles and cardiomyopathy LAMP-2-deficient mice. Nature 406:902\u2013906. https:\/\/doi.org\/10.1038\/35022595","journal-title":"Nature"},{"key":"2310_CR56","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ajpath.2015.02.015","volume":"185","author":"A Furuta","year":"2015","unstructured":"Furuta A, Kikuchi H, Fujita H et al (2015) Property of lysosomal storage disease associated with midbrain pathology in the central nervous system of lamp-2-deficient mice. Am J Pathol 185:1713\u20131723. https:\/\/doi.org\/10.1016\/j.ajpath.2015.02.015","journal-title":"Am J Pathol"},{"key":"2310_CR57","doi-asserted-by":"publisher","first-page":"12692","DOI":"10.1074\/jbc.274.18.12692","volume":"274","author":"N Andrejewski","year":"1999","unstructured":"Andrejewski N, Punnonen EL, Guhde G et al (1999) Normal lysosomal morphology and function in LAMP-1-deficient mice. J Biol Chem 274:12692\u201312701. https:\/\/doi.org\/10.1074\/jbc.274.18.12692","journal-title":"J Biol Chem"},{"key":"2310_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12032-022-01871-0","volume":"40","author":"SU Khan","year":"2022","unstructured":"Khan SU, Fatima K, Aisha S et al (2022) Redox balance and autophagy regulation in cancer progression and their therapeutic perspective. Med Oncol 40:12. https:\/\/doi.org\/10.1007\/s12032-022-01871-0","journal-title":"Med Oncol"},{"key":"2310_CR59","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10238-022-00955-5","volume":"23","author":"SU Khan","year":"2023","unstructured":"Khan SU, Rayees S, Sharma P, Malik F (2023) Targeting redox regulation and autophagy systems in cancer stem cells. Clin Exp Med 23:1405\u20131423. https:\/\/doi.org\/10.1007\/s10238-022-00955-5","journal-title":"Clin Exp Med"},{"key":"2310_CR60","doi-asserted-by":"publisher","unstructured":"Leidal AM, Debnath J (2014) Doubling down \u2019 on the autophagy pathway to suppress tumor growth. 1137\u20131139. https:\/\/doi.org\/10.1101\/gad.244681.114.with","DOI":"10.1101\/gad.244681.114.with"},{"key":"2310_CR61","doi-asserted-by":"publisher","unstructured":"Peyraud F, Italiano A (2020) Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors. Cancers (Basel) 12. https:\/\/doi.org\/10.3390\/cancers12061502","DOI":"10.3390\/cancers12061502"},{"key":"2310_CR62","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1158\/0008-5472.CAN-18-2652","volume":"78","author":"RA Stewart","year":"2018","unstructured":"Stewart RA, Pilie PG, Yap TA (2018) Development of PARP and immune-checkpoint inhibitor combinations. Cancer Res 78:6717\u20136725. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2652","journal-title":"Cancer Res"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02310-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02310-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02310-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:58:41Z","timestamp":1779281921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02310-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2310"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02310-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animal participants were in accordance with NIH 252 guidelines for the use of laboratory animals. Additionally, Animal management followed the \u201cARRIVE\u201d 253 guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"136"}}